Pancreatic cancer projected to become second leading cause of cancer-related death in the US by 2030

May 20, 2014, American Association for Cancer Research
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain

(Medical Xpress)—An analysis projects pancreatic and liver cancers to become second and third leading causes of cancer-related death in the United States by 2030, respectively, behind lung cancer, which will remain the number one killer, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

According to the projections by the Pancreatic Cancer Action Network in Manhattan Beach, Calif., which conducted the research, breast, prostate, and lung cancers will remain the top three diagnoses in 2030. Colorectal cancer, which is currently the fourth leading cancer diagnosis, will be replaced by thyroid cancer, followed by melanoma and uterine cancers in fifth and sixth places, respectively. Lung cancer will remain the top killer, but pancreatic and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer death, respectively.

"The projections for deaths from pancreatic and liver cancers are startling," said Lynn Matrisian, Ph.D., MBA, vice president of scientific and medical affairs at the Pancreatic Cancer Action Network. "This study is a call to action to the scientific and clinical communities, as well as the population at large, to increase attention, awareness, and ultimately progress in the fight against pancreatic cancer."

The researchers estimated the cancer incidence and death rates by taking into account two important factors: The first is changes in demographics, caused by an increase in the number of aging baby boomers and increase in minority populations, some of whom have higher rates of cancer incidence and death. The second factor is changes in the average annual percentage of cancer incidence and deaths, influenced by factors such as better screening and prevention methods, and prevalence of smoking and viral infections.

The projected decrease in incidence is attributed to advances in screening and the projected increase in thyroid is a consequence of increased diagnosis, which is not accompanied by an increase in deaths, explained Matrisian.

"Overall, it is encouraging that the cancer death rate in the United States is declining each year, and the numbers of deaths caused by several major cancers are following that trend and dropping," said Matrisian. "The scientific and clinical research communities must bring successes from other cancer types to bear on tackling pancreatic and liver cancers and improving outcomes for patients."

Historically, pancreatic cancer is a disease that is understudied and underfunded, explained Matrisian. The pancreas is located deep within the abdomen and is difficult to access and visualize by imaging modalities. In addition, are surrounded and infiltrated by dense stromal tissue that is thought to impede drug delivery. This is further complicated by data suggesting pancreatic tumors metastasize early in the disease course.

"The Pancreatic Cancer Action Network has a comprehensive approach to fighting this disease through research, patient support, community outreach, and advocacy for a cure," Matrisian added. "In an effort to double survival by 2020, the network is intensifying efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments, and increase chances of survival."

Explore further: Bacteria in mouth may diagnose pancreatic cancer

Related Stories

Bacteria in mouth may diagnose pancreatic cancer

May 18, 2014
Patients with pancreatic cancer have a different and distinct profile of specific bacteria in their saliva compared to healthy controls and even patients with other cancers or pancreatic diseases, according to research presented ...

Microfluidic technology reveals potential biomarker for early pancreatic cancer

April 29, 2014
Cancer cells are on the move in the bloodstream in the very early stage of pancreatic cancer, and can be detected before cancer is diagnosed, according to research by the University of Michigan Health System.

Novel drug cocktail may improve clinical treatment for pancreatic cancer

May 1, 2014
Pancreatic cancer is the fourth leading cause of cancer deaths in the U.S. and has the lowest overall survival rate of all major cancers (~6%). With current treatment options being met with limited success it is anticipated ...

'Achilles heel' of pancreatic cancer identified

May 1, 2014
A research team at Georgetown Lombardi Comprehensive Cancer Center reports that inhibiting a single protein completely shuts down growth of pancreatic cancer, a highly lethal disease with no effective therapy.

Screen some patients with acute pancreatitis for pancreatic cancer, researchers suggest

February 26, 2014
In a study published in Clinical Gastroenterology and Hepatology, Saint Louis University researchers have found a link between acute pancreatitis (inflammation of the pancreas) and pancreatic cancer, a finding which may eventually ...

Death rates from pancreatic cancer predicted to rise in Europe in 2014

April 23, 2014
Pancreatic cancer is the only cancer for which deaths are predicted to increase in men and women rather than decrease in 2014 and beyond, according to a comprehensive study published in the leading cancer journal Annals of ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.